InsidersTradesSigma
Track the 리센스메디컬 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 리센스메디컬 has published 10 insider filings. Market capitalisation: €114.5bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 김건호. All data is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations10 total
Other
10 of 10 declarations
Acerca de 리센스메디컬
리센스메디컬 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo de soluciones médicas innovadoras.